Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
For the prophylaxis and treatment of infections caused by erythromycin-sensitive organisms.
Erythromycin is highly effective in the treatment of a great variety of clinical infections such as:
Tablets for oral administration. Tablets should be swallowed whole and taken before or with meals.
For mild to moderate infections, 1 g to 2 g a day, in divided doses. Up to 4g daily in severe infections.
No modified dosage recommendations.
Note: For younger children, infants and babies, Porphyrocin, erythromycin ethylsuccinate suspensions, are normally recommended. The recommended dose for children age 2-8 years, for mild to moderate infections, is 1 gram daily in divided doses. The recommended dose for infants and babies, for mild to moderate infections, is 500 mg daily in divided doses. For severe infections doses may be doubled.
Typical symptoms of overdose include severe nausea, diarrhea, vomiting and hearing loss.
Treatment should be by gastric lavage and general supportive measures.
3 years.
Store below 25°C in the original package to be protected from light.
Tablets are supplied in aluminium foil-polyvinylchloride film blisters of ten tablets. Packs of 20 and 100 tablets, with a patient information leaflet, in a card carton are available. Dispensing packs of 100, 250, 500 or 1000 tablets are also available.
Not all pack sizes may be marketed.
None.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.